[Pharma-clinics. The drug of the month. Nevirapine. Viramune].
Nevirapine is the first non nucleoside reverse transcriptase inhibitor registered in Belgium and indicated in the treatment of HIV-1 infection. In association with 2 nucleoside analogues, its efficiency is similar to a tritherapy with protease inhibitor, particularly in naive patients with low viral load. It has a good tolerance profile and is easy to take. Studies in progress should permit to widen its indications.
Nkoghe
D
D
Service de Médecine interne-Infectiologie, Université de Liège.
Léonard
P
P
Moutschen
M
M
Demonty
J
J
D019380:Anti-HIV Agents / Q000494:pharmacology* / Q000627:therapeutic use; D015658:HIV Infections / Q000188:drug therapy*; D015497:HIV-1; D006801:Humans; D019829:Nevirapine / Q000494:pharmacology* / Q000627:therapeutic use; D019562:Viral Load
D019380:Anti-HIV Agents; D019829:Nevirapine